This topic contains a solution. Click here to go to the answer

Author Question: All of the following individuals are at high risk for having a stroke except: a. someone who smokes ... (Read 83 times)

stevenposner

  • Hero Member
  • *****
  • Posts: 608
All of the following individuals are at high risk for having a stroke except:
 a. someone who smokes at least 1 pack of cigarettes a day.
  b. someone with elevated LDL levels.
  c. someone with a blood pressure of 175/95.
  d. someone with elevated high-density lipoproteins.

Question 2

The difference between an ischemic stroke vs. a hemorrhagic stroke is:
 a. artery occlusion vs. ruptured artery.
  b. traveling clot vs. ruptured artery.
  c. ruptured artery vs. artery occlusion.
  d. artery occlusion vs. traveling clot.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fraziera112

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

d

Answer to Question 2

a




stevenposner

  • Member
  • Posts: 608
Reply 2 on: Aug 20, 2018
Thanks for the timely response, appreciate it


apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library